Ashland Reports Q2 Revenue of $482M, Below Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy ASH?
Reports Q2 revenue $482M, consensus $485.61M. "Ashland's second quarter results reflect commercial execution across much of the portfolio as we navigated a challenging operating environment with generally resilient demand," said Guillermo Novo, chair and chief executive officer of Ashland. "Sales increased modestly year-over-year, driven by strength in Personal Care, resilient performance in Life Sciences, and stabilization in Specialty Additives. Life Sciences delivered steady results, supported by strong customer engagement and continued volume growth in pharma applications, reflecting sustained demand in injectables and oral solid-dosage excipients. Personal Care generated broad-based growth, led by double-digit gains in biofunctional actives and solid execution across skin care, hair care, and microbial protection. In Specialty Additives, coatings returned to growth on share gains, while we reduced our construction exposure on portfolio mix management, and energy markets were softer in the Middle East due to the ongoing conflict. In Intermediates, demand and pricing were stable at trough levels, with disciplined commercial and operating actions supporting profitability."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ASH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ASH
Wall Street analysts forecast ASH stock price to rise
9 Analyst Rating
6 Buy
3 Hold
0 Sell
Moderate Buy
Current: 57.000
Low
53.00
Averages
66.67
High
73.00
Current: 57.000
Low
53.00
Averages
66.67
High
73.00
About ASH
Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company’s segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ashland Reports Q2 Fiscal 2026 Earnings Insights
- Slow Sales Growth: Ashland reported Q2 sales of $482 million, a 1% year-over-year increase, but profitability was impacted by internal manufacturing issues, with adjusted EBITDA at $98 million, down 9%, indicating challenges in operational execution.
- Manufacturing Execution Pressure: The CFO noted that the manufacturing optimization benefit at Hopewell was reduced by $10 million to $12 million due to startup delays and weather-related disruptions, reflecting delays in production capacity enhancement that affect overall profit expectations.
- Outlook Adjustment: Management revised the fiscal 2026 sales outlook to $1.835 billion to $1.87 billion and adjusted EBITDA to $385 million to $400 million, reflecting the impact of softer energy demand tied to the Middle East conflict and reduced EV demand, while emphasizing resilient demand in core markets.
- Stable Financial Position: Despite operational disruptions, Ashland maintained liquidity of approximately $939 million and net debt just over $1 billion, resulting in a net leverage ratio of about 2.7x, demonstrating financial robustness amid rising external cost pressures.
See More
Ashland Reports Q2 2026 Financial Results and Updates Guidance
- Sales Growth: Ashland's Q2 sales reached $482 million, a 1% increase year-over-year, primarily driven by strong performance in Personal Care, indicating resilience in consumer markets despite softness in Intermediates.
- Net Income Decline: Net income fell to $16 million from $31 million a year ago, reflecting operational challenges at the Hopewell facility and weather-related disruptions, highlighting the need for improved operational management amidst internal challenges.
- Adjusted EBITDA Decrease: Adjusted EBITDA was $98 million, down 9% year-over-year, primarily due to delays in the Calvert City startup and productivity issues, underscoring the urgency for the company to enhance operational efficiency.
- Strong Cash Flow: Cash flows from operating activities totaled $50 million, a significant improvement from $9 million in the prior year, demonstrating effective capital management and cash generation, thereby enhancing financial stability.
See More
Ashland Q2 Results Miss Expectations with Updated Guidance
- Disappointing Performance: Ashland's Q2 Non-GAAP EPS of $0.91 misses expectations by $0.03, indicating pressure on profitability that could undermine investor confidence.
- Slight Revenue Increase: The company reported revenue of $482 million, a 0.6% year-over-year increase, yet it fell short of market expectations by $3.61 million, reflecting soft market demand and intensified competition.
- Sales Guidance Update: Ashland has revised its fiscal 2026 sales guidance to a range of $1.835 billion to $1.870 billion, below the consensus estimate of $1.85 billion, highlighting uncertainty in future market conditions.
- Narrowed EBITDA Guidance: The company has adjusted its adjusted EBITDA guidance to a range of $385 million to $400 million, indicating that innovation and cost control measures are still effective despite demand softness.
See More
ASHLAND: FY ADJUSTED EPS PROJECTION EXCLUDING INTANGIBLES AMORTIZATION SHOWS MID-TO-HIGH SINGLE-DIGIT GROWTH
Economic Outlook: The outlook for FY A has been adjusted, indicating changes in economic forecasts and expectations.
Exclusion of Intangibles: The analysis specifically excludes intangible assets, focusing on tangible growth metrics.
Mid-to-High Single-Digit Growth: The report anticipates a growth rate in the mid-to-high single digits, suggesting a positive trend in economic performance.
Market Implications: These adjustments and growth expectations may have significant implications for market strategies and investment decisions.
See More
ASHLAND REPORTS SECOND QUARTER NET INCOME OF $16 MILLION
- Company Overview: Ashland reported a net income of USD 16 million for the quarter.
- Financial Performance: The financial results indicate a significant performance metric for the company during this period.
See More
Ashland Announces Q2 Fiscal 2026 Earnings Release Schedule
- Earnings Release Schedule: Ashland Inc. plans to issue its Q2 fiscal 2026 earnings report on April 28, 2026, at 5 p.m. ET, showcasing the company's performance across various markets and future outlook, which is expected to impact investor confidence.
- Live Webcast Conference: The company will hold a live webcast on April 29, 2026, at 9 a.m. ET, where executives will provide detailed financial analysis and strategic direction, enhancing interaction with investors.
- Executive Participation: The conference will feature several executives, including CEO Guillermo Novo and CFO William Whitaker, demonstrating the leadership's commitment to financial transparency, aimed at boosting investor trust.
- Investor Relations Materials: Following the event, Ashland will provide an archived version of the webcast and supporting materials on its investor relations website, ensuring investors can access information at any time, further promoting transparency and accessibility.
See More
Ashland Reports Q2 Fiscal 2026 Earnings Insights
- Slow Sales Growth: Ashland reported Q2 sales of $482 million, a 1% year-over-year increase, but profitability was impacted by internal manufacturing issues, with adjusted EBITDA at $98 million, down 9%, indicating challenges in operational execution.
- Manufacturing Execution Pressure: The CFO noted that the manufacturing optimization benefit at Hopewell was reduced by $10 million to $12 million due to startup delays and weather-related disruptions, reflecting delays in production capacity enhancement that affect overall profit expectations.
- Outlook Adjustment: Management revised the fiscal 2026 sales outlook to $1.835 billion to $1.87 billion and adjusted EBITDA to $385 million to $400 million, reflecting the impact of softer energy demand tied to the Middle East conflict and reduced EV demand, while emphasizing resilient demand in core markets.
- Stable Financial Position: Despite operational disruptions, Ashland maintained liquidity of approximately $939 million and net debt just over $1 billion, resulting in a net leverage ratio of about 2.7x, demonstrating financial robustness amid rising external cost pressures.
See More
Ashland Reports Q2 2026 Financial Results and Updates Guidance
- Sales Growth: Ashland's Q2 sales reached $482 million, a 1% increase year-over-year, primarily driven by strong performance in Personal Care, indicating resilience in consumer markets despite softness in Intermediates.
- Net Income Decline: Net income fell to $16 million from $31 million a year ago, reflecting operational challenges at the Hopewell facility and weather-related disruptions, highlighting the need for improved operational management amidst internal challenges.
- Adjusted EBITDA Decrease: Adjusted EBITDA was $98 million, down 9% year-over-year, primarily due to delays in the Calvert City startup and productivity issues, underscoring the urgency for the company to enhance operational efficiency.
- Strong Cash Flow: Cash flows from operating activities totaled $50 million, a significant improvement from $9 million in the prior year, demonstrating effective capital management and cash generation, thereby enhancing financial stability.
See More
Ashland Q2 Results Miss Expectations with Updated Guidance
- Disappointing Performance: Ashland's Q2 Non-GAAP EPS of $0.91 misses expectations by $0.03, indicating pressure on profitability that could undermine investor confidence.
- Slight Revenue Increase: The company reported revenue of $482 million, a 0.6% year-over-year increase, yet it fell short of market expectations by $3.61 million, reflecting soft market demand and intensified competition.
- Sales Guidance Update: Ashland has revised its fiscal 2026 sales guidance to a range of $1.835 billion to $1.870 billion, below the consensus estimate of $1.85 billion, highlighting uncertainty in future market conditions.
- Narrowed EBITDA Guidance: The company has adjusted its adjusted EBITDA guidance to a range of $385 million to $400 million, indicating that innovation and cost control measures are still effective despite demand softness.
See More
ASHLAND: FY ADJUSTED EPS PROJECTION EXCLUDING INTANGIBLES AMORTIZATION SHOWS MID-TO-HIGH SINGLE-DIGIT GROWTH
Economic Outlook: The outlook for FY A has been adjusted, indicating changes in economic forecasts and expectations.
Exclusion of Intangibles: The analysis specifically excludes intangible assets, focusing on tangible growth metrics.
Mid-to-High Single-Digit Growth: The report anticipates a growth rate in the mid-to-high single digits, suggesting a positive trend in economic performance.
Market Implications: These adjustments and growth expectations may have significant implications for market strategies and investment decisions.
See More
ASHLAND REPORTS SECOND QUARTER NET INCOME OF $16 MILLION
- Company Overview: Ashland reported a net income of USD 16 million for the quarter.
- Financial Performance: The financial results indicate a significant performance metric for the company during this period.
See More
Ashland Announces Q2 Fiscal 2026 Earnings Release Schedule
- Earnings Release Schedule: Ashland Inc. plans to issue its Q2 fiscal 2026 earnings report on April 28, 2026, at 5 p.m. ET, showcasing the company's performance across various markets and future outlook, which is expected to impact investor confidence.
- Live Webcast Conference: The company will hold a live webcast on April 29, 2026, at 9 a.m. ET, where executives will provide detailed financial analysis and strategic direction, enhancing interaction with investors.
- Executive Participation: The conference will feature several executives, including CEO Guillermo Novo and CFO William Whitaker, demonstrating the leadership's commitment to financial transparency, aimed at boosting investor trust.
- Investor Relations Materials: Following the event, Ashland will provide an archived version of the webcast and supporting materials on its investor relations website, ensuring investors can access information at any time, further promoting transparency and accessibility.
See More
